Lifeward Overview
- Year Founded
-
2001
- Status
-
Public
- Employees
-
81
- Stock Symbol
-
LFWD
- Investments
-
3
- Share Price
-
$4.06
- (As of Friday Closing)
Lifeward General Information
Description
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions spanning the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings include the ReWalk Personal Exoskeleton, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. The company operates in the United States, which generates the majority of its revenue, as well as in Europe, Germany, Asia Pacific, and the rest of the world.
Contact Information
Website
www.golifeward.comCorporate Office
- 3 Hatnufa Street, 6th Floor
- PO Box 161
- Yokneam Ilit 2069203
- Israel
Corporate Office
- 3 Hatnufa Street, 6th Floor
- PO Box 161
- Yokneam Ilit 2069203
- Israel
Lifeward Timeline
Lifeward Stock Performance
As of 13-Nov-2026, Lifeward’s stock price is $4.06. Its current market cap is $11.5M with 2.84M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.06 | $5.72 | $3.81 - $9.61 | $11.5M | 2.84M | 11.1K | -$16.09 |
Lifeward Financials Summary
As of 30-Jun-2026, Lifeward has a trailing 12-month revenue of $21.8M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 18,950 | 8,829 | 5,566 | 16,192 |
| Revenue | 21,822 | 22,034 | 25,663 | 13,854 |
| EBITDA | (23,891) | (19,324) | (25,701) | (21,652) |
| Net Income | (30,830) | (19,914) | (28,942) | (22,133) |
| Total Assets | 35,000 | 22,900 | 30,487 | 63,192 |
| Total Debt | 6,988 | 4,387 | 880 | 1,903 |
Lifeward Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Lifeward Comparisons
Industry
Financing
Details
Lifeward Competitors (10)
One of Lifeward’s 10 competitors is Myomo, a Formerly VC-backed company based in Burlington, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Myomo | Formerly VC-backed | Burlington, MA | ||||
| Tyromotion | Private Equity-Backed | Graz, Austria | ||||
| Ekso Bionics Holdings | Formerly VC-backed | Richmond, CA | ||||
| Bionik Laboratories | Formerly PE-Backed | Toronto, Canada | ||||
| Cyberdyne | Formerly VC-backed | Tsukuba, Japan |
Lifeward Patents
Lifeward Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026006499-A1 | Motorized height adjustable cockpit for differential air pressure system | Pending | 25-Jun-2024 | ||
| EP-4816130-A1 | Exoskeleton and smart crutch systems | Pending | 27-Nov-2023 | ||
| US-20260316258-A1 | Exoskeleton and smart crutch systems | Pending | 27-Nov-2023 | ||
| WO-2025117860-A1 | Exoskeleton and smart crutch systems | Inactive | 27-Nov-2023 | ||
| EP-4333777-A1 | Dynamic orthosis | Active | 03-May-2021 | A61F5/013 |
Lifeward Signals
Lifeward Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Lifeward Investments & Acquisitions (3)
Lifeward’s most recent deal was a Merger/Acquisition with OraTech Pharmaceuticals for . The deal was made on 25-Mar-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| OraTech Pharmaceuticals | 25-Mar-2026 | Merger/Acquisition | Drug Delivery | ||
| Skelable (Certain Technology Assets, Related Know-How and Functional Prototypes) | 25-Feb-2026 | Corporate Asset Purchase | Buildings and Property | ||
| AlterG | 11-Aug-2023 | Merger/Acquisition | Therapeutic Devices |
Lifeward ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
33.29 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Lifeward Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| AlterG | Fremont, CA | 2005 |
Lifeward FAQs
-
When was Lifeward founded?
Lifeward was founded in 2001.
-
Where is Lifeward headquartered?
Lifeward is headquartered in Yokneam Ilit, Israel.
-
What is the size of Lifeward?
Lifeward has 81 total employees.
-
What industry is Lifeward in?
Lifeward’s primary industry is Therapeutic Devices.
-
Is Lifeward a private or public company?
Lifeward is a Public company.
-
What is Lifeward’s stock symbol?
The ticker symbol for Lifeward is LFWD.
-
What is the current stock price of Lifeward?
As of 13-Nov-2026 the stock price of Lifeward is $4.06.
-
What is the current market cap of Lifeward?
The current market capitalization of Lifeward is $11.5M.
-
What is Lifeward’s current revenue?
The trailing twelve month revenue for Lifeward is $21.8M.
-
Who are Lifeward’s competitors?
Myomo, Tyromotion, Ekso Bionics Holdings, Bionik Laboratories, and Cyberdyne are some of the 10 competitors of Lifeward.
-
What is Lifeward’s annual earnings per share (EPS)?
Lifeward’s EPS for 12 months was -$16.09.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process